Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes Gernee Investor was very imprecise in his answer stating ".. several weeks..". It is so hard for me to do my TA with type of a reply.
He should have at least said "several weeks plus or minus.." or "..approximately several weeks.." or "..in the neighborhood of several weeks.."
Are you saying that any disease trialed using blarcamesine (A2-73) would be fast tracked?
Only 3 other greens showing on my watch list and one of those shows $0.00 increase at the moment. It certainly is a good feeling knowing we (us longs) are holding a true gem.
I pray to God that Anavex can move as fast as possible and the FDA,EMA, and TGA will act expeditiously to complete trials and grant approval to make blarcamasine available to everyone.
I don't know about when he is in front of only the RETT family but he is presenting on "Epilepsy Pipeline" March 13th I believe.
Since RETT patients experience seizures I would imagine that he will address RETT treatment then.
I agree Benny. There are likely many "new eyes" each day looking at this message board and George is keeping them well informed of all of the past news about AVXL as well as new information.
Keep it up George. Thank you for doing this. Once the new "eyes" see some of the positive news they can dig deeper with Xena's excellent compilation.
Regarding Data Monitoring Committee, when there were discussions about when Aricept was approved I seemed to recall that it was approved upon the DMC review. I briefly tried to find confirmation of that but did notspend much time on it. I am am quite certain that I remembered correctly however.
Good work George.You were very precient !
Jon Jones-"Missling may need to be replaced" ?
I believe that Dr. Misssling does not independently make all of the decisions regarding what information is to be made public. Anavex has a very strong management team as well as a SAB consisting of all of the most respected CNS experts in the various areas. I do not think all of these would sit silently by and let Dr. Missling totally control trials and information releases.
If Dr. Missling needs to be replaced then all of the aforementioned advisers should be replaced also.
My belief is that since there are so many billions of dollars at stake they are being most careful to avoid another bigger "Cortina" event. IMO
Jon Jones-"Replac Missling" ?
I believe that Dr. Misssling does not independently make all of the decisions regarding what information is to be made public. Anavex has a very strong management team as well as a SAB consisting of all of the most respected CNS experts in the various areas. I do not think all of these would sit silently by and let Dr. Missling totally control trials and information releases.
If Dr. Missling needs to be replaced then all of the aforementioned advisers should be replaced also.
My belief is that since there are so many billions of dollars at stake they are being most careful to avoid another bigger "Cortina" event. IMO
Thank you. I am assuming that there will be near the 100 Million authorized shares issued as we near completion of AD approval but still very healthy share price.
JWC3 - Would you please show your calculations that produces an estimated share price of between $2600 to $13,400. My calculations result in considerably lessor numbers. T/Y
Jav033 -my guess is that won''t happen after 4 separate PRs announcing partnerships on RETT, AZ, PDD, and MS along with 3 more separate PRs announcing Provisional Approval for blarcamesine to treat RETT, AZ, and PDD. All of these tomorrow morning at 0406 hours (EST).
Happy New Year to all of the longs and especially to all of you with expertise in various disciplines that share your knowledge with all of us. It is most appreciated.
Investor and Wolf Thank you for the good laugh this morning.
I needed it to get my lung working after 11 days in the hospital with a third time pneumothorax within six months.
I never was a heavy or long term smoker that quit 40 years ago and I have never huffed cocaine so the only thing that I can come up with is that it must be that agonizing effect of A2-73 that I have held for about as long as Fred Knoll and Park West have.
Wishing all long term investors a very Happy and Prosperous 2020 and beyond.
Jon Jones You stated in part "By now Missling and the gang know what we have." I would pssibly state this a little differently.
About 4 or 5 years Dr. Missling had met wuth a congressional committee and in that meeting he stated (to paraphrase) "We know what we have and we have no fear" or something to that effect.
A couple years later he said again to paraphrase " As this is getting bigger it is getting much more complicated"
My take is all of the delays were created by the fact that this has become much larger than Anavex even envisioned at the early stages.
I think Dr. Missling. management team , and the SAB have done a masterful job of playing three dimensional chess and have brought us to this point of last moves before the capture.
Hey Alzheimer’s Association, how about running a quick multiple choice poll in your next monthly magazine. Let’s see what the patients/caregivers have to say
What and find a possible answer that might put our money making operation our of business.
Simonizer and Mac - Its interesting to see how Avxl trades in the after hours and pre hours when a free effective market operates then what happens after the market makers (SEC authorized thieves) come to work.
Can anyone explain to me just what controls the SEC has on them?
talon-This is very interesting. I didn't take time to look at other presentations. I would like to be there for that session. My feeling is that Australia is ready to move ahead with any good solid results which I hope Anavex will be able to present shortly.
(Note to Investor. I am not sure where that shortly) lies in the hierarchy of suddenness)
Talon-it appears to me that these poster presentations and the late breaking oral presentation are all to prove validity of using AI in clinical trials while referencing blarcamesine studies. All of the listed presenters are from Ariana and not by Anavex. AI appears to be the overall theme of this CTAD IMO.
Certainly the emphasis using blarcamesine is great but I don't expect any solid trial information to be presented here. I don't expect to hear anything new until 12/11 at the annual fiscal report presentation. What are your thoughts?
Correction to my previous post. It was Post #221080 by Xena
Maybe Dr. Woodcock head of CDER of FDA doesn't agree with the current system either. Quoting Dr. Woodcock from a link 221042 posted by XENA today
"People say they want placebo-controlled trials, but I always ask them would you be willing to die to give a p-value?" she added.
Power-Thank you for clearing this up for me. I had interpreted(or misinterpreted) it as complete silence of announcing anything that could possibly affect share price before the 10-K was published.
Jimmy Question for you: With CTAD scheduled for Dec 4-7 will the year end 10-K be presented prior to comply with the "QUIET PERIOD" requirement?
1. Quiet Period — The period beginning on the quarter-end date and ending at the time of the earnings release for that quarter should be observed as a quiet period with no formal or informal business discussions by management with analysts or investors.
Guidelines for Communication with the Investment Community ...
www.investor.jnj.com › guidelines
Question. With CTAD scheduled for Dec 4-7 will the year end 10-K be presented prior to comply with the "QUIET PERIOD" requirement?
1. Quiet Period — The period beginning on the quarter-end date and ending at the time of the earnings release for that quarter should be observed as a quiet period with no formal or informal business discussions by management with analysts or investors.
Guidelines for Communication with the Investment Community ...
www.investor.jnj.com › guidelines
BIOPHARMADIVE
BRIEF
Biogen's R&D head is out, following string of clinical setbacks
abew4me - I'm not sure if TGA will be presenting at CTAD as he is presenting in Boston on 12/5 at the Gut-Brain Summit
I don't know what time Dr. Missling is presenting in Boston but even if it the last presentation of the day there would be 27 hours before he would present at CTAD. It doesn't take long to fly across country.
CTAD has been a very important venue for Anavex in the past so IMO he will be presenting there.
I believe this was posted about a month ago.
Job Type: Full-time
Salary: $80,000.00 to $110,000.00 /year
Experience:
Protocol or IB Writing: 1 year (Required)
Pharmaceutical: 2 years (Required)
Education:
Bachelor's (Required)
Additional Compensation:
Bonuses
Benefits:
Health insurance
Dental insurance
Vision insurance
Retirement plan
Paid time off
23 days ago
https://www.indeed.com/m/viewjob?jk=9801b19a285f4029&from=serp&prevUrl=https%3A%2F%2Fwww.indeed.com%2Fm%2Fjobs%3FsameL%3D1%26q%3DAnavex%26l%3D%26from%3DsearchOnSerp
BOOK NOW
ASM- Alzheimer's Trials Beyond Amyloid
hero
AC4R; Annual scientific meeting of Alzheimer researchers in Australasia to discuss and facilitate diagnostic and treatment research in Alzheimer's disease.
On Friday 11 October 2019 at 9:00am
LOCATION
The Sutherland Room - Holme Building
Level 4, Holme Building, Science Road, University of Sydney, NSW 2006
CONTACT DETAILS
CONTACT EVENT ORGANISER
Thank you OSO. I read this last week or so when you posted it before and forgot about it. I read about happy hours years back when I got on the ihub but had forgotten about that.
(Do me a favor and remind me next Friday At my age I need reminders. LOL)
This board is populated with so many great contributors of which you are one. May God bless you all.
Let us pray that this is a very solid week for Anavex.
No apologies needed Power. I'm an old retired investor here that has the time to read practically every message posted on this outstanding board. Thanks to all of you experts here that share your vast and deep knowledge of the sciences and investing with those of us that were old time engineers etc.
(I just wished we had more ignores available to us.)
Good luck and God Bless all involved with Anavex to hopefully reduces and or eliminate some of the terrible maladies of humanity.
I'm aware of that Power. He and I have had comments back and forth. My mother immigrated from Denmark.
I believe Denmark is one hour behind Finland. One doesn't know just how short of a workday Investor puts in but I am certain he will feel it is his duty to have a great report ready and posted for those of us sleeping in.
Power I appreciate all of your input on the board along with many many others.
We will thank you for sacrificing and getting up to have your fried mackerel in chocolate sauce an hour earlier than normal to listen live and be able to give us a thorough analysis when we get up.
I always look forward to your posts and especially the subtle jabs responding to some questions.
Dr.Kauffman is scheduled to presentat 10:05 Finland time
Which is +7 hrs ahead of East Coast time.
This would be 0300 hrs as I see it or
3:00 AM on the East Coast.
Power this deserves a standing ovation. Well done.
It looks like the NASDQ pre-market doesn't open until 8:15 EDT
McMagyar- You were certainly correct in your response (and ahead of the published information) to my Post #208929 regarding the up coming presentation at the Janney Conference by Anavex when I wrote "A very, very, very, exclusive investment banking firm at a ...."
You responded "Don’t get too excited..
the special people ran over the cliff twice with Biogen to the time of $60-$70 Billion" at 11:30 AM on Monday. I don't think I saw that the announcement of the Janney Conference being cancelled until about 5:00 PM on Monday and that Yun Zhong had been fired in Bourbon's Post # 208976 at 5:34 PM - "Janney has removed from Yun Zhong's analyst coverage page the fact that he covers AVXL and NTRP. Both were listed as recently as end of August."
I am so very appreciative for all of the excellent very experienced posters on this message board. It is most informative and reassuring to me
Thanks for this info. On my last call the operator gave me that message and hung up. Sounded very rushed so maybe he just screwed up.
I'll listen to the replay.
Anavex presentation today
Apparently the guy that told me to stand by which I did when I first called in was misinformed also.
I called back in and very quickly told that the Anavex presentation was cancelled.
I miss stated. I should have said I called in and they took my info and told me to stand by. 800 954 0621
I just logged in to Conference services
As an oldster I'll take $60 billion this week!